Ailem Rabasa

828 total citations
14 papers, 681 citations indexed

About

Ailem Rabasa is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology. According to data from OpenAlex, Ailem Rabasa has authored 14 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Oncology and 8 papers in Immunology. Recurrent topics in Ailem Rabasa's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (7 papers) and HER2/EGFR in Cancer Research (7 papers). Ailem Rabasa is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (7 papers) and HER2/EGFR in Cancer Research (7 papers). Ailem Rabasa collaborates with scholars based in Cuba, United States and Netherlands. Ailem Rabasa's co-authors include Greta Garrido, Glen N. Barber, Tianli Xia, Jeonghyun Ahn, Luis E. Fernández, Rolando Pérez, Ariel Talavera, Ernesto Moreno, Alejandro López‐Requena and Rune Johansen and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Cancer Cell.

In The Last Decade

Ailem Rabasa

14 papers receiving 674 citations

Peers

Ailem Rabasa

ONCOL

IMMUN

RNMI

PRM

Greta Garrido Cuba

Karl Hoermann Germany

Melanie Straub Germany

Marta Osorio Cuba

Mauricio Catalá Cuba

Brian J. Francica United States

Benjamin Cottam United States

Xiaochuan Chen China

Conor McKenna United Kingdom

Olga Radkevich-Brown United States

Greta Garrido Cuba

Ailem Rabasa

388 ×1.0

ONCOL

175 ×0.6

IMMUN

171 ×0.8

181 ×1.1

RNMI

167 ×1.1

PRM

Citations per year, relative to Ailem Rabasa Ailem Rabasa (= 1×) peers Greta Garrido

Countries citing papers authored by Ailem Rabasa

Since Specialization

Citations

This map shows the geographic impact of Ailem Rabasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailem Rabasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailem Rabasa more than expected).

Fields of papers citing papers by Ailem Rabasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailem Rabasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailem Rabasa. The network helps show where Ailem Rabasa may publish in the future.

Co-authorship network of co-authors of Ailem Rabasa

This figure shows the co-authorship network connecting the top 25 collaborators of Ailem Rabasa. A scholar is included among the top collaborators of Ailem Rabasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailem Rabasa. Ailem Rabasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Garrido, Greta, Brett Schrand, Agata Levay, et al.. (2020). Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. Cancer Immunology Research. 8(7). 856–868. 8 indexed citations

Garrido, Greta, Brett Schrand, Ailem Rabasa, et al.. (2019). Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity. Nature Communications. 10(1). 3773–3773. 50 indexed citations

Schrand, Brett, Agata Levay, Ailem Rabasa, et al.. (2018). Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nature Communications. 9(1). 3348–3348. 18 indexed citations

Ahn, Jeonghyun, et al.. (2018). Extrinsic Phagocyte-Dependent STING Signaling Dictates the Immunogenicity of Dying Cells. Cancer Cell. 33(5). 862–873.e5. 144 indexed citations

Garrido, Greta, et al.. (2017). Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab. Frontiers in Pharmacology. 8. 595–595. 33 indexed citations

Garrido, Greta, Ailem Rabasa, Cristina Garrido, et al.. (2013). Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms. Oncogene. 33(24). 3129–3139. 31 indexed citations

Garrido, Greta, Ailem Rabasa, & Belinda Sánchez Pérez. (2013). Linking oncogenesis and immune system evasion in acquired resistance to EGFR-targeting antibodies. OncoImmunology. 2(12). e26904–e26904. 2 indexed citations

Rabasa, Ailem, et al.. (2012). Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its Fragment in an Immunocompetent Mouse Model. PubMed. 2012. 1–8. 6 indexed citations

Garrido, Greta, Ailem Rabasa, Eric C. Yang, et al.. (2011). Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile. Cancer Biology & Therapy. 11(4). 373–382. 123 indexed citations

10.

Garrido, Greta, Ailem Rabasa, Belinda Sánchez Pérez, et al.. (2011). Induction of Immunogenic Apoptosis by Blockade of Epidermal Growth Factor Receptor Activation with a Specific Antibody. The Journal of Immunology. 187(10). 4954–4966. 72 indexed citations

11.

Garrido, Greta, et al.. (2009). Abstract #2763: Binding properties of the anti-EGFR monoclonal antibody, nimotuzumab, limit interaction with the EGFR in renal and epidermal cells. Cancer Research. 69. 2763–2763. 4 indexed citations

12.

Alpízar, Yeranddy A., et al.. (2009). HER1-ECD vaccination dispenses with emulsification to elicit HER1-specific anti-proliferative effects. Human Vaccines. 5(3). 158–165. 7 indexed citations

13.

Talavera, Ariel, Rosmarie Friemann, C. Martinez-Fleites, et al.. (2009). Nimotuzumab, an Antitumor Antibody that Targets the Epidermal Growth Factor Receptor, Blocks Ligand Binding while Permitting the Active Receptor Conformation. Cancer Research. 69(14). 5851–5859. 160 indexed citations

14.

Alpízar, Yeranddy A., et al.. (2008). Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine. Vaccine. 26(38). 4918–4926. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact